pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
olutasidenib
Rezlidhia (olutasidenib)
Refractory Acute Myeloid Leukemia
$RIGLRIGEL PHARMACEUTICALS INC
0 catalysts
Phase 3
olverembatinib
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Bcr/Abl fusion protein
$AAPGASCENTAGE PHARMA GROUP INTERNATIONAL
0 catalysts
Phase 3
olvimulogene nanivacirepvec
Endometrial Cancer
$GNLXGENELUX Corp
← prev
page 53 of 62
next →
131
Pain89
Neurology1
0 catalysts
Marketed
omacetaxine mepesuccinate
Myelodysplastic Syndrome (Preleukemia)
$TEVATEVA PHARMACEUTICAL INDUSTRIES LTD
0 catalysts
Marketed
omeprazole magnesium DR
Omeprazole Magnesium (omeprazole magnesium)
Systemic Mastocytosis
Perrigo Pharmaceuticals Company (Inactive)
0 catalysts
Phase 3
omidubicel
Omisirge (omidubicel-onlv)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Gamida Cell Ltd
0 catalysts
Phase 2
ompenaclid succinate
Metastatic Colorectal Cancer
Inspirna Inc
0 catalysts
Preclinical
onCARlytics
Triple-Negative Breast Cancer (TNBC)
Imugene Ltd
0 catalysts
Phase 3
onfekafusp alfa
onfekafusp alfa [INN]
Soft Tissue Sarcoma
Philogen SpA
0 catalysts
Phase 2
onvansertib fumarate
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
$CRDFCardiff Oncology, Inc.
0 catalysts
Phase 2
onvapegleukin alfa
Cervical Cancer
Ascendis Pharma AS
0 catalysts
Phase 2
opaganib
YELIVA (opaganib [INN])
Bile Duct Cancer (Cholangiocarcinoma)
$RDHLRedHill Biopharma Ltd.
0 catalysts
Phase 2
ordastobart
Adenocarcinoma Of The Gastroesophageal Junction
$INBXInhibrx Biosciences, Inc.
0 catalysts
Phase 3
oregovomab
Ovarex (oregovomab)
Fallopian Tube Cancer
Mucin-16
OncoQuest Inc
0 catalysts
Phase 3
orelabrutinib
Primary Progressive Multiple Sclerosis (PPMS)
Tyrosine-protein kinase BTK
$ZBIOZenas BioPharma, Inc.
0 catalysts
Phase 2
orvacabtagene autoleucel
Refractory Multiple Myeloma
Bristol-Myers Squibb Co
0 catalysts
Phase 2
osemitamab
Gastroesophageal (GE) Junction Carcinomas
Transcenta Holding Ltd
0 catalysts
Marketed
osimertinib mesylate
Tagrisso (osimertinib mesylate)
Non-Small Cell Lung Cancer
Epidermal growth factor receptor
$AZNASTRAZENECA PLC
0 catalysts
pre_registration
ozekibart
Chondrosarcoma
$INBXInhibrx Biosciences, Inc.
0 catalysts
Phase 2
ozuriftamab vedotin
Head And Neck Cancer
$BCABBioAtla, Inc.
0 catalysts
Marketed
paclitaxel albumin bound
Abraxane (paclitaxel)
Non-Small Cell Lung Cancer
Celgene Corp
0 catalysts
Phase 3
padeliporfin potassium
Transitional Cell Cancer (Urothelial Cell Cancer)
ImPact Biotech Limited
0 catalysts
Phase 2
palacaparib
palacaparib [INN]
Malignant Glioma
$AZNASTRAZENECA PLC
0 catalysts
Phase 3
palazestrant
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
$OLMAOlema Pharmaceuticals, Inc.
0 catalysts
Marketed
palbociclib
Ibrance (palbociclib)
Breast Cancer
$OTLCOncotelic Therapeutics, Inc.
0 catalysts
Marketed
pamidronate disodium
Pamidronate Disodium (pamidronate disodium)
Osteolytic Lesion
Areva Pharmaceuticals Inc
0 catalysts
Phase 2
pamlectabart tismanitin
pamlectabart tismanitin [INN]
Refractory Multiple Myeloma
Heidelberg Pharma AG
0 catalysts
Marketed
panitumumab
Vectibix (panitumumab)
Metastatic Colorectal Cancer
$AMGNAMGEN INC
0 catalysts
Phase 3
pasritamig
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
$JNJJOHNSON & JOHNSON
0 catalysts
Phase 3
patidegib hydrochloride
Gorlin Syndrome (Basal Cell Nevus Syndrome/ Nevoid Basal Cell Carcinoma Syndr…
$SLGLSol-Gel Technologies Ltd.
0 catalysts